JP Morgan Chase
CPHI icon

JP Morgan Chase’s China Pharma Holdings CPHI Stock Holding History

JP Morgan Chase’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40
Closed -$78 – 7488
2025
Q3 		$78 Buy
+40
New +$68 ﹤0.01% 7190
2024
Q1 		– Sell
-1,308
Closed -$7.92K – 7474
2023
Q4 		$7.92K Buy
+1,308
New +$7.34K ﹤0.01% 6467

Other funds holding CPHI

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

JP Morgan Chase's CPHI Position: Q4 2025 in Review

JP Morgan Chase sold out of China Pharma Holdings (CPHI) in Q4 2025, closing a stake of 40 shares — an estimated $78 sold.

JP Morgan Chase first reported a position in CPHI in Q4 2023 and held it in 2 quarters. The position peaked at $7.92K in Q4 2023. 5 funds tracked by Wall St. Rank hold CPHI as of Q4 2025.

  • JP Morgan Chase reported no remaining China Pharma Holdings position as of Q4 2025 after selling out during the quarter.
  • JP Morgan Chase sold 40 China Pharma Holdings shares in Q4 2025, an estimated $78.
  • JP Morgan Chase first reported a position in China Pharma Holdings in Q4 2023 and held it in 2 quarters.
  • JP Morgan Chase's China Pharma Holdings position peaked at $7.92K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q4 2025.

Based on JP Morgan Chase's 13F filing for Q4 2025, filed 11 Feb 2026.